Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2021-08-23 00:00:00 ET · period of report 2021-08-20 · accession 0001420506-21-001337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-23 | 2021-08-20 | CLPT | BURNETT JOSEPH MICHAEL | CEO, Pres, Dir | A - Grant | $0.00 | +14.7K | 241.4K | +6% | $0 |
| D | 2021-08-23 | 2021-08-20 | CLPT | BURNETT JOSEPH MICHAEL | CEO, Pres, Dir | A - Grant | $0.00 | +29.4K | 29.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | A | A | 14,688 | $0.00 | 241,424 | D | — | — | (F1) The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. |
| 2 | Derivative | Stock Options (right to buy) | 2021-08-20 | A | A | 29,377 | $0.00 | 29,377 | D | $16.71 · — to 2031-08-20 | 29,377 Common Stock | (F2) The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. |